Titre:
  • D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study.
Auteur:Duffaud, F; van der Burg, Maria; Namer, Moïse; Vergote, Ignace; Willemse PHB, B; ten Bokkel Huinink, Wim; Guastalla, Jean Paul; Nooij, j; Kerbrat, Pierre; Piccart-Gebhart, Martine; Tumolo, Salvatore; Favalli, Giuseppe; van der Vange, N; Lacave, Ángel Jiménez; Wils, J; Splinter, Ted; Einhorn, N; Roozendaal, K J; Rosso, Riccardo; Vermorken, Jan Baptist
Informations sur la publication:Anti-cancer drugs, 12, 2, page (159-162)
Statut de publication:Publié, 2001-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal -- therapeutic use
Carcinoma -- drug therapy
Carcinoma -- mortality
Drug Evaluation
Drug Resistance
Female
Humans
Middle Aged
Neoplasm Staging
Ovarian Neoplasms -- drug therapy
Ovarian Neoplasms -- mortality
Platinum Compounds -- therapeutic use
Salvage Therapy
Survival Rate
Treatment Outcome
Triptorelin -- therapeutic use
Note générale:Clinical Trial
Evaluation Studies
Journal Article
Multicenter Study
Langue:Anglais
Identificateurs:urn:issn:0959-4973
info:pmid/11261890